Who backs CORXEL Pharmaceuticals?
13 investors| Investor | Type |
|---|---|
| RA Capital Management | Asset manager |
| New Enterprise Associates | Venture capital |
| The Invus Group | PE / buyout |
| SR One Capital Management | Other |
| RTW Investments | Hedge fund |
| Adage Capital Management | Hedge fund |
| SilverArc Capital Management | Hedge fund |
| Apeloa Pharmaceutical | — |
| Bayer (Conglomerates) | — |
| HBM Healthcare Investments | — |
| + 3 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
CORXEL Pharmaceuticals investors
13 investors are on record for CORXEL Pharmaceuticals, including RA Capital Management, New Enterprise Associates, The Invus Group and SR One Capital Management. By type, the record holds 3 hedge funds, 1 venture capital firm and 1 asset manager. The Series D1 in Jan 2026 drew 9 investors.
Free account
More of CORXEL Pharmaceuticals with a free account
- ·The complete investor list: 13 names
- ·Watch CORXEL Pharmaceuticals: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 13 firms already write checks for companies like CORXEL Pharmaceuticals in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View